{"transactions":[{"id":740222,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":38855,"kind":"person","name":"Chapman Gina","position":1,"cik":"0001989220","reported_name":"Chapman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-12T17:16:38.000Z","date":"2026-06-10","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) the one-year anniversary of June 10, 2026 or (ii) the Issuer's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":5.97,"expiration_date":"2036-06-10","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001689375-26-000043","document":"wk-form4_1781298996.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1989220/000168937526000043/wk-form4_1781298996.xml","form_type":"4"}},{"id":1113771,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":38855,"kind":"person","name":"Chapman Gina","position":1,"cik":"0001989220","reported_name":"Chapman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T08:04:56.000Z","date":"2025-06-11","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) the one-year anniversary of June 11, 2025 or (ii) the Issuer's next annual meeting of stockholders."}],"balance_after":19000,"derivative":{"exercise_price":7.9,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001689375-25-000030","document":"wk-form4_1749729890.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1989220/000168937525000030/wk-form4_1749729890.xml","form_type":"4"}},{"id":1200529,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":38855,"kind":"person","name":"Chapman Gina","position":1,"cik":"0001989220","reported_name":"Chapman Gina","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2025-03-18T16:16:18.000Z","date":"2025-03-14","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting. 1/16th of the RSUs vest on each quarterly anniversary measured from January 1, 2025 (the \"Vesting Commencement Date\"), such that 100% of the RSUs will be fully vested on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":303905,"source":{"system":"sec-edgar","filing":"0001610717-25-000069","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1989220/000161071725000069/form4.xml","form_type":"4"}},{"id":1401742,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":38855,"kind":"person","name":"Chapman Gina","position":1,"cik":"0001989220","reported_name":"Chapman Gina","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-20T17:24:58.000Z","date":"2024-09-19","kind":"exercise","planned":true,"acquired":false,"shares":2975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vest on the first anniversary measured from February 9, 2023 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":549515,"derivative":{"exercise_price":5.03,"expiration_date":"2033-04-20","underlying":"Common Stock","underlying_shares":2975},"source":{"system":"sec-edgar","filing":"0001610717-24-000492","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1989220/000161071724000492/form4.xml","form_type":"4"}},{"id":1401741,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":38855,"kind":"person","name":"Chapman Gina","position":1,"cik":"0001989220","reported_name":"Chapman Gina","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-09-20T17:24:58.000Z","date":"2024-09-18","kind":"exercise","planned":true,"acquired":false,"shares":7166,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the option vest on the first anniversary measured from February 9, 2023 (the \"Vesting Commencement Date\"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":552490,"derivative":{"exercise_price":5.03,"expiration_date":"2033-04-20","underlying":"Common Stock","underlying_shares":7166},"source":{"system":"sec-edgar","filing":"0001610717-24-000492","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1989220/000161071724000492/form4.xml","form_type":"4"}},{"id":1401740,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":38855,"kind":"person","name":"Chapman Gina","position":1,"cik":"0001989220","reported_name":"Chapman Gina","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-09-20T17:24:58.000Z","date":"2024-09-19","kind":"sale","planned":true,"acquired":false,"shares":2975,"price":25.0275,"value":74456.8125,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 25, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades in prices ranging from $25.00 to $25.15, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":103905,"source":{"system":"sec-edgar","filing":"0001610717-24-000492","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1989220/000161071724000492/form4.xml","form_type":"4"}},{"id":1401739,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":38855,"kind":"person","name":"Chapman Gina","position":1,"cik":"0001989220","reported_name":"Chapman Gina","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-09-20T17:24:58.000Z","date":"2024-09-19","kind":"exercise","planned":true,"acquired":true,"shares":2975,"price":5.03,"value":14964.25,"ownership":{"direct":true},"balance_after":106880,"source":{"system":"sec-edgar","filing":"0001610717-24-000492","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1989220/000161071724000492/form4.xml","form_type":"4"}},{"id":1401738,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":38855,"kind":"person","name":"Chapman Gina","position":1,"cik":"0001989220","reported_name":"Chapman Gina","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-09-20T17:24:58.000Z","date":"2024-09-18","kind":"sale","planned":true,"acquired":false,"shares":7166,"price":25.0872,"value":179774.8752,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 25, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades in prices ranging from $25.00 to $25.44, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote."}],"balance_after":103905,"source":{"system":"sec-edgar","filing":"0001610717-24-000492","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1989220/000161071724000492/form4.xml","form_type":"4"}},{"id":1401737,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":38855,"kind":"person","name":"Chapman Gina","position":1,"cik":"0001989220","reported_name":"Chapman Gina","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2024-09-20T17:24:58.000Z","date":"2024-09-18","kind":"exercise","planned":true,"acquired":true,"shares":7166,"price":5.03,"value":36044.98,"ownership":{"direct":true},"balance_after":111071,"source":{"system":"sec-edgar","filing":"0001610717-24-000492","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1989220/000161071724000492/form4.xml","form_type":"4"}},{"id":1479433,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":38855,"kind":"person","name":"Chapman Gina","position":1,"cik":"0001989220","reported_name":"Chapman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-14T16:33:33.000Z","date":"2024-06-13","kind":"grant","planned":false,"acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable on the earlier of (i) the one-year anniversary of June 13, 2024  or (ii) the Issuer's next annual meeting of\nstockholders."}],"balance_after":16000,"derivative":{"exercise_price":16.45,"expiration_date":"2034-06-13","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001689375-24-000034","document":"wk-form4_1718397205.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1989220/000168937524000034/wk-form4_1718397205.xml","form_type":"4"}},{"id":1603706,"issuer":{"id":76319,"kind":"organization","name":"CARGO Therapeutics, Inc.","symbol":"CRGX"},"owners":[{"id":38855,"kind":"person","name":"Chapman Gina","position":1,"cik":"0001989220","reported_name":"Chapman Gina","relationship":{"director":true,"officer":true,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-03-04T16:20:10.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":400000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2024 (the \"Vesting Commencement Date\"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date."}],"balance_after":400000,"derivative":{"exercise_price":25.07,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":400000},"source":{"system":"sec-edgar","filing":"0001610717-24-000112","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1989220/000161071724000112/form4.xml","form_type":"4"}},{"id":1789519,"issuer":{"id":2163,"kind":"organization","name":"Entrada Therapeutics, Inc.","symbol":"TRDA"},"owners":[{"id":38855,"kind":"person","name":"Chapman Gina","position":1,"cik":"0001989220","reported_name":"Chapman Gina","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-09-05T16:31:54.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in equal monthly installments over three years from the date of grant, subject to the reporting person's continuous service through the applicable vesting date."}],"balance_after":32000,"derivative":{"exercise_price":15.41,"expiration_date":"2033-09-01","underlying":"Common Stock","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001689375-23-000060","document":"wf-form4_169394589181133.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1989220/000168937523000060/wf-form4_169394589181133.xml","form_type":"4"}}]}